Global Molecular Diagnostics and NAT Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Table of Contents

1 Molecular Diagnostics and NAT Market Overview

• 1.1 Product Overview and Scope of Molecular Diagnostics and NAT
• 1.2 Classification of Molecular Diagnostics and NAT by Type
  • 1.2.1 Global Molecular Diagnostics and NAT Revenue by Type: 2015 VS 2019 VS 2025
  • 1.2.2 Global Molecular Diagnostics and NAT Revenue Market Share by Type in 2019
  • 1.2.3 Amplification Technologies
  • 1.2.4 Amplified Gene Detection Technologies
  • 1.2.5 DNA And Oligonucleotide Microarrays
  • 1.2.6 Gene Sequencing
• 1.3 Global Molecular Diagnostics and NAT Market by Application
  • 1.3.1 Overview: Global Molecular Diagnostics and NAT Revenue by Application: 2015 VS 2019 VS 2025
  • 1.3.2 Hospitals and Clinics
  • 1.3.3 Research Institutes
  • 1.3.4 Diagnostic Centers
• 1.4 Global Molecular Diagnostics and NAT Market by Regions
  • 1.4.1 Global Molecular Diagnostics and NAT Market Size by Regions: 2015 VS 2019 VS 2025
  • 1.4.2 Global Market Size of Molecular Diagnostics and NAT (2015-2025)
  • 1.4.3 North America (USA, Canada and Mexico) Molecular Diagnostics and NAT Status and Prospect (2015-2025)
  • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Molecular Diagnostics and NAT Status and Prospect (2015-2025)
  • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Molecular Diagnostics and NAT Status and Prospect (2015-2025)
  • 1.4.6 South America (Brazil, Argentina, Colombia) Molecular Diagnostics and NAT Status and Prospect (2015-2025)
  • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Molecular Diagnostics and NAT Status and Prospect (2015-2025)

2 Company Profiles

• 2.1 Roche
  • 2.1.1 Roche Details
  • 2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.1.3 Roche SWOT Analysis
  • 2.1.4 Roche Product and Services
  • 2.1.5 Roche Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2018-2019)
• 2.2 GenMark
  • 2.2.1 GenMark Details
  • 2.2.2 GenMark Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.2.3 GenMark SWOT Analysis
  • 2.2.4 GenMark Product and Services
  • 2.2.5 GenMark Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2018-2019)
• 2.3 Biomerieux
  • 2.3.1 Biomerieux Details
  • 2.3.2 Biomerieux Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.3.3 Biomerieux SWOT Analysis
  • 2.3.4 Biomerieux Product and Services
  • 2.3.5 Biomerieux Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2018-2019)
• 2.4 Abbott
  • 2.4.1 Abbott Details
  • 2.4.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.4.3 Abbott SWOT Analysis
  • 2.4.4 Abbott Product and Services
  • 2.4.5 Abbott Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2018-2019)
• 2.5 Agilent
  • 2.5.1 Agilent Details
  • 2.5.2 Agilent Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.5.3 Agilent SWOT Analysis
  • 2.5.4 Agilent Product and Services
  • 2.5.5 Agilent Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2018-2019)
• 2.6 BD
  • 2.6.1 BD Details
  • 2.6.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.6.3 BD SWOT Analysis
  • 2.6.4 BD Product and Services
  • 2.6.5 BD Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2018-2019)
• 2.7 AutoGenomics
  • 2.7.1 AutoGenomics Details
  • 2.7.2 AutoGenomics Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.7.3 AutoGenomics SWOT Analysis
  • 2.7.4 AutoGenomics Product and Services
  • 2.7.5 AutoGenomics Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2018-2019)
• 2.8 Thermo Fisher Scientific
  • 2.8.1 Thermo Fisher Scientific Details
  • 2.8.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.8.3 Thermo Fisher Scientific SWOT Analysis
  • 2.8.4 Thermo Fisher Scientific Product and Services
  • 2.8.5 Thermo Fisher Scientific Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2018-2019)
• 2.9 Qiagen
  • 2.9.1 Qiagen Details
  • 2.9.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.9.3 Qiagen SWOT Analysis
  • 2.9.4 Qiagen Product and Services
  • 2.9.5 Qiagen Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2018-2019)
• 2.10 Siemens Healthcare
  • 2.10.1 Siemens Healthcare Details
  • 2.10.2 Siemens Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.10.3 Siemens Healthcare SWOT Analysis
  • 2.10.4 Siemens Healthcare Product and Services
  • 2.10.5 Siemens Healthcare Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

• 3.1 Global Molecular Diagnostics and NAT Revenue and Share by Players (2015-2020)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Molecular Diagnostics and NAT Players Market Share
  • 3.2.2 Top 10 Molecular Diagnostics and NAT Players Market Share
• 3.3 Market Competition Trend

4 Market Size by Regions

• 4.1 Global Molecular Diagnostics and NAT Revenue and Market Share by Regions
• 4.2 North America Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
• 4.3 Europe Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
• 4.4 Asia-Pacific Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
• 4.5 South America Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
• 4.6 Middle East & Africa Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)

5 North America Molecular Diagnostics and NAT Revenue by Countries

• 5.1 North America Molecular Diagnostics and NAT Revenue by Countries (2015-2020)
• 5.2 USA Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
• 5.3 Canada Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
• 5.4 Mexico Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)

6 Europe Molecular Diagnostics and NAT Revenue by Countries

• 6.1 Europe Molecular Diagnostics and NAT Revenue by Countries (2015-2020)
• 6.2 Germany Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
• 6.3 UK Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
• 6.4 France Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
• 6.5 Russia Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
• 6.6 Italy Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Molecular Diagnostics and NAT Revenue by Countries

• 7.1 Asia-Pacific Molecular Diagnostics and NAT Revenue by Countries (2015-2020)
• 7.2 China Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
• 7.3 Japan Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
• 7.4 Korea Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
• 7.5 India Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
• 7.6 Southeast Asia Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)

8 South America Molecular Diagnostics and NAT Revenue by Countries

• 8.1 South America Molecular Diagnostics and NAT Revenue by Countries (2015-2020)
• 8.2 Brazil Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
• 8.3 Argentina Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Molecular Diagnostics and NAT by Countries

• 9.1 Middle East & Africa Molecular Diagnostics and NAT Revenue by Countries (2015-2020)
• 9.2 Saudi Arabia Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
• 9.3 UAE Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
• 9.4 Egypt Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)
• 9.5 South Africa Molecular Diagnostics and NAT Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

• 10.1 Global Molecular Diagnostics and NAT Revenue and Market Share by Type (2015-2020)
• 10.2 Global Molecular Diagnostics and NAT Market Forecast by Type (2019-2024)
• 10.3 Amplification Technologies Revenue Growth Rate (2015-2025)
• 10.4 Amplified Gene Detection Technologies Revenue Growth Rate (2015-2025)
• 10.5 DNA And Oligonucleotide Microarrays Revenue Growth Rate (2015-2025)
• 10.6 Gene Sequencing Revenue Growth Rate (2015-2025)

11 Global Molecular Diagnostics and NAT Market Segment by Application

• 11.1 Global Molecular Diagnostics and NAT Revenue Market Share by Application (2015-2020)
• 11.2 Molecular Diagnostics and NAT Market Forecast by Application (2019-2024)
• 11.3 Hospitals and Clinics Revenue Growth (2015-2020)
• 11.4 Research Institutes Revenue Growth (2015-2020)
• 11.5 Diagnostic Centers Revenue Growth (2015-2020)

12 Global Molecular Diagnostics and NAT Market Size Forecast (2021-2025)

• 12.1 Global Molecular Diagnostics and NAT Market Size Forecast (2021-2025)
• 12.2 Global Molecular Diagnostics and NAT Market Forecast by Regions (2021-2025)
• 12.3 North America Molecular Diagnostics and NAT Revenue Market Forecast (2021-2025)
• 12.4 Europe Molecular Diagnostics and NAT Revenue Market Forecast (2021-2025)
• 12.5 Asia-Pacific Molecular Diagnostics and NAT Revenue Market Forecast (2021-2025)
• 12.6 South America Molecular Diagnostics and NAT Revenue Market Forecast (2021-2025)
• 12.7 Middle East & Africa Molecular Diagnostics and NAT Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Data Source
• 14.3 Disclaimer